Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis

Abstract

Background Psychiatric morbidities have been associated with a risk of severe infections through compromised immunity, health behaviours, or both. However, data are scarce on the association between multiple types of pre-pandemic psychiatric disorders and COVID-19. We aimed to assess the association between pre-pandemic psychiatric disorders and the subsequent risk of COVID-19 using UK Biobank. Methods For this cohort analysis, we included participants from UK Biobank who were registered in England and excluded individuals who died before Jan 31, 2020, (the start of the COVID-19 outbreak in the UK) or had withdrawn from UK Biobank. Participants diagnosed with a psychiatric disorder before Jan 31 were included in the group of individuals with pre-pandemic psychiatric disorders, whereas participants without a diagnosis before the outbreak were included in the group of individuals without pre-pandemic psychiatric disorders. We used the Public Health England dataset, UK Biobank hospital data, and death registers to collect data on COVID-19 cases. To examine the relationship between pre-pandemic psychiatric disorders and susceptibility to COVID-19, we used logistic regression models to estimate odds ratios (ORs), controlling for multiple confounders and somatic comorbidities. Key outcomes were all COVID-19, COVID-19 specifically diagnosed in inpatient care, and COVID-19-related deaths. ORs were also estimated separately for each psychiatric disorder and on the basis of the number of pre-pandemic psychiatric disorders. As a positive disease control, we repeated analyses for hospitalisation for other infections. Findings We included 421 014 UK Biobank participants in our study and assessed their COVID-19 status between Jan 31 and July 26, 2020. 50 809 participants were diagnosed with psychiatric disorders before the outbreak, while 370 205 participants had no psychiatric disorders. The mean age at outbreak was 67·80 years (SD 8·12). We observed an elevated risk of COVID-19 among individuals with pre-pandemic psychiatric disorders compared with that of individuals without such conditions. The fully adjusted ORs were 1·44 (95% CI 1·28–1·62) for All COVID-19 cases, 1·55 (1·34–1·78) for Inpatient COVID-19 cases, and 2·03 (1·59–2·59) for COVID-19-related deaths. We observed excess risk, defined as risk that increased with the number of pre-pandemic psychiatric disorders, across all diagnostic categories of pre-pandemic psychiatric disorders. We also observed an association between psychiatric disorders and elevated risk of hospitalisation due to other infections (OR 1·74, 95% CI 1·58–1·93). Interpretation Our findings suggest that pre-existing psychiatric disorders are associated with an increased risk of COVID-19. These findings underscore the need for surveillance of and care for populations with pre-existing psychiatric disorders during the COVID-19 pandemic. Funding National Natural Science...

A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders

“…Several observational studies ( An et al, 2020 ; Batty et al, 2021 ; Cavallaro et al, 2020 ; Collaborative, 2021 ; Cummins et al, 2021 ; Fond et al, 2020 ; Giannoglou et al, 2020 ; Hirashima et al, 2021 ; Jeon et al, 2020 ; Lee et al, 2020a ; Lee et al, 2020b ; McKeigue et al, 2020 ; Nemani et al, January 2021 in JAMA psychiatry; Wang et al, 2020 ; Yang et al, 2020 ; Yanover et al, 2020 ) investigated whether people with mental disorders have poorer COVID-19 outcomes or not, thus we have decided to conduct this meta-analysis that aims to investigate the relationship between pre diagnosed psychiatric illness and COVID-19 mortality and severity suggesting that people with mental disorders might have worse outcome of COVID-19.…”

Promoting the Resilience of the Italian Population Against SARS-CoV-2

“…Yang et al ( 73 ) show that psychiatric hospitalization before the pandemic was associated with elevated odds of COVID-19 diagnosis (OR 1.44, 95% CI 1.28–1.62), COVID-19 inpatient hospitalization (1.55, 1.34–1.78), and COVID-19–related death (2.03, 1.59–2.59).…”

Psychotic disorders in COVID-19: mechanisms of development, clinical and treatment features

“…З другого боку, у ретроспективному дослідженні «випадок -конт ро ль» 219 961 осіб віком старших за 18 років з лабораторно підтвердженим діагнозом COVID-19 показано, що розлади внаслідок вживання психоактивних речовин і шизо фре нія можуть бути факторами ризику COVID-19 [3]. Подібні результати отри мано і під час аналізу даних британського Біобанку, де було виявлено, що психічні розлади, які виникли до пандемії COVID-19, були пов'язані з подальшим підвищеним ризиком COVID-19, особливо госпіталізації і смертності в зв'язку з COVID-19 [4].…”

“…В гострій стадії захворювань, що їх спричинили віруси SARS і MERS, сплутаність свідомості є звичайним проявом, тоді як делірій є серйозною клінічною проблемою [4]. Окрім типових особливостей делірію, у пацієнтів можуть виявляти підвищений тонус або ригідність, абулію, алогію та ознаки значної системної запальної реакції [9,18].…”